by nms-sync | Feb 18, 2026 | News
Milan, Italy, 18 February 2026 Benta has announced the acquisition of NerPharMa, a pharmaceutical manufacturing company located in Milan, Italy, from NMS Group. The acquisition marks a significant step in strengthening Benta’s European industrial platform and...
by nms-sync | Jul 28, 2025 | News
NERVIANO, Italy, 28 July 2025 — NerPharMa (NPM), a renowned Contract Development and Manufacturing Organization (CDMO) specializing in oncology and in immunology, today announced the appointment of Serena Alvino, MBA, CIPP/E, as its new Chief Executive Officer,...
by nms-sync | Jul 9, 2025 | News
Nerviano, Italy – 09 July 2025 – NMS Group S.p.A., the largest oncology-focused R&D organization in Italy, today announced the appointment of Mr. Victor Chu to its Board of Directors, effective immediately. Mr. Chu replaces Mr. Lincoln Pan, who has stepped...
by nms-sync | Sep 11, 2024 | News
NERVIANO, IT, September 11, 2024 – NMS Group S.p.A. (NMS Group), the largest oncological R&D company in Italy, announces today a change to its shareholding structure, leading to a restructured board of directors and statutory auditors. The Fondazione Regionale per...
by nms-sync | Sep 2, 2024 | News
NERVIANO, IT, September 2, 2024 NerPharMa Srl (NerPharMa, part of the NMS Group), a leading Contract Development and Manufacturing Organization (CDMO), is pleased to announce the appointment of Vittorio Montanaro as Industrial Operation Site Head and member of the...
by nms-sync | Sep 2, 2024 | News
NERVIANO, IT, September 2, 2024 SIMIS S.r.l. (SIMIS), a part of NMS Group S.p.A. (NMS Group) and a company provides services to the community domiciled in Nerviano Bio-Park, today announced the appointment of Marco Dieci as the new Chief Executive Officer, effective...
Recent Comments